Back to News
Market Impact: 0.35

Why Zoetis (ZTS) Could Beat Earnings Estimates Again

ZTS
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsHealthcare & Biotech
Why Zoetis (ZTS) Could Beat Earnings Estimates Again

Zoetis (ZTS), an animal health company, is positioned for another potential earnings beat, according to analysis highlighting its consistent outperformance. The company has surpassed consensus estimates in its last two quarters by an average of 3.95%, including a 5.71% surprise in the most recent report. This trend, coupled with a positive Zacks Earnings ESP of +1.10% and a Zacks Rank #3 (Hold), suggests a high probability of continued earnings strength ahead of its next report scheduled for August 5, 2025.

Analysis

Zoetis (ZTS) exhibits a strong track record of outperforming earnings expectations, a trend that forward-looking indicators suggest may continue. The company has surpassed consensus earnings per share (EPS) estimates in its last two reports, with an average surprise of 3.95%. The most recent quarter saw a significant 5.71% beat, with reported EPS of $1.48 versus an estimate of $1.40. This historical performance is complemented by a positive Zacks Earnings ESP (Expected Surprise Prediction) of +1.10%, which implies that recent analyst revisions are trending more bullish than the standing consensus. The combination of this positive ESP and the stock's Zacks Rank #3 (Hold) is presented as a historically reliable predictor, with a nearly 70% probability of leading to another earnings beat in its upcoming report on August 5, 2025. The analysis is predicated on a quantitative model focused on predicting earnings surprises, not necessarily the subsequent stock price movement.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo